You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Marstacimab

From EverybodyWiki Bios & Wiki

Marstacimab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetTFPI
Clinical data
SynonymsPF-06741086
ATC code
  • none
Identifiers
CAS Number
UNII
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}
Chemical and physical data
FormulaC6304H9766N1678O2006S44
Molar mass142.6 g/mol g·mol−1

Marstacimab (PF-06741086) (INN) is a monoclonal antibody designed for the prevention of bleeding in patients with hemophilia.[1][2]

This drug is being developed by Pfizer Inc.

References[edit]

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Marstacimab, American Medical Association.
  2. World Health Organization (2018). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 119" (PDF). WHO Drug Information. 32 (2).


This article "Marstacimab" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Marstacimab. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.